Co-Authors
This is a "connection" page, showing publications co-authored by Phulen Sarma and Ajay Prakash.
Connection Strength
3.762
-
Are your capsules vegetarian or nonvegetarian: An ethical and scientific justification. Indian J Pharmacol. 2017 Sep-Oct; 49(5):401-404.
Score: 0.731
-
nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis. Sci Rep. 2021 06 18; 11(1):12888.
Score: 0.238
-
Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review. Indian J Pharmacol. 2021 May-Jun; 53(3):236-243.
Score: 0.236
-
Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian J Pharmacol. 2020 Nov-Dec; 52(6):535-550.
Score: 0.228
-
Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients. Indian J Pharmacol. 2020 Sep-Oct; 52(5):414-421.
Score: 0.225
-
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). J Biomol Struct Dyn. 2021 05; 39(8):2724-2732.
Score: 0.221
-
Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. J Med Virol. 2020 07; 92(7):776-785.
Score: 0.220
-
Intellectual property rights and Indian pharmaceutical industry: Present scenario. Indian J Pharmacol. 2018 Mar-Apr; 50(2):57-60.
Score: 0.189
-
Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy. Indian J Pharmacol. 2018 Jan-Feb; 50(1):1-3.
Score: 0.187
-
Update on geographical variation and distribution of SARS-nCoV-2: A systematic review. Indian J Pharmacol. 2021 Jul-Aug; 53(4):310-316.
Score: 0.060
-
Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jul-Aug; 53(4):317-327.
Score: 0.060
-
Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review. Phytother Res. 2021 Aug; 35(8):4456-4484.
Score: 0.059
-
Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review. Eur J Pharmacol. 2021 Sep 05; 906:174233.
Score: 0.059
-
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD. Comput Biol Med. 2021 07; 134:104495.
Score: 0.059
-
Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings. J Biomol Struct Dyn. 2021 May 13; 1-11.
Score: 0.059
-
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? Med Hypotheses. 2021 Apr; 149:110539.
Score: 0.058
-
Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review. Biomed Pharmacother. 2021 May; 137:111300.
Score: 0.058
-
Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Tissue Cell. 2021 Jun; 70:101497.
Score: 0.058
-
Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep. 2021 Jun; 73(3):736-749.
Score: 0.058
-
Indian contribution toward biomedical research and development in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jan-Feb; 53(1):63-72.
Score: 0.058
-
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations. mSystems. 2020 Sep 22; 5(5).
Score: 0.057
-
Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence. Vet Res Commun. 2020 Nov; 44(3-4):119-130.
Score: 0.056
-
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. J Mol Graph Model. 2020 12; 101:107716.
Score: 0.056
-
Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review. Life Sci. 2020 Oct 01; 258:118207.
Score: 0.056
-
Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol. 2020 Jul-Aug; 52(4):313-323.
Score: 0.056
-
A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virol Sin. 2020 Jun; 35(3):290-304.
Score: 0.056
-
Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown. Indian J Pharmacol. 2020 Mar-Apr; 52(2):75-78.
Score: 0.055
-
COVID-19 pandemic: A review based on current evidence. Indian J Pharmacol. 2020 Mar-Apr; 52(2):117-129.
Score: 0.055
-
Update on the target structures of SARS-CoV-2: A systematic review. Indian J Pharmacol. 2020 Mar-Apr; 52(2):142-149.
Score: 0.055
-
Modulation of endocannabinoid system: Success lies in the failures. Indian J Pharmacol. 2018 Jul-Aug; 50(4):155-158.
Score: 0.048
-
Three-dimensional drugs: A new era in the pharmaceutical development. Indian J Pharmacol. 2017 Nov-Dec; 49(6):417-418.
Score: 0.046
-
Congenital malformation and autism spectrum disorder: Insight from a rat model of autism spectrum disorder. Indian J Pharmacol. 2017 May-Jun; 49(3):243-249.
Score: 0.045